Valneva Seeks to Extend Use of Chikungunya Vaccine with Label Extension Submissions
Sep 19, 2024
Vaccine Invest Information
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications
Sep 18, 2024
Bharat Biotech Introduces Groundbreaking Oral Cholera Vaccine as Global Demand Soars
Aug 28, 2024
Valneva's Innovative IXCHIQ® Becomes the First Chikungunya Vaccine Authorized in Europe
Jul 1, 2024
U.S. Health Authorities Advocate for RSV Vaccinations for Seniors, Impacting Pfizer's PFE Stake
Jun 27, 2024
Valneva Showcases Innovative Chikungunya Vaccine at World Vaccine Congress
Mar 21, 2024
ICMR Study Finds No Link Between Covid Vaccines and Heart Attacks
Mar 3, 2024
Decline in Cervical Cancer Mortality Rates as India Prepares to Implement HPV Vaccine Program
Jan 15, 2024
Valneva SE's Single-Dose Vaccine Proves Long-Lasting Immunity in Trial
Dec 8, 2023
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva
Nov 10, 2023
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises
Nov 10, 2023